Enhancement of Spinosyn Production by Integrating a Static and Dynamic CRISPRi-Mediated Metabolic Switch in Saccharopolyspora spinosa
Journal of Agricultural and Food Chemistry · 2025
DOI: 10.1021/acs.jafc.5c08276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, 2025. Verfasst von Wenfang Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Shanghai Normal University, Shanghai 200234, China. Hauptthemen laut MEDLINE: Saccharopolyspora, Macrolides, Bacterial Proteins, Insecticides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
Spinosyns, polyketide-derived macrolide insecticides produced by Saccharopolyspora spinosa, have broad market prospects. However, their large-scale production is still challenged by the low titers of industrial strains. Here, we developed an integrated static and dynamic CRISPRi strategy to redirect metabolic flux toward spinosyn overproduction without affecting cell growth. Initially, static CRISPRi-mediated repression of four genes (gltA1, fabH3, fabH4, and glgC) in three key nodes of primary metabolism boosted spinosyn titers by 19-55% without growth impairment. Simultaneous repression of these genes led to a further increase of spinosyn production. However, static repression of two other genes (pyc or gltA2) severely hindered bacterial growth and reduced spinosyn biosynthesis. To address this, two growth phase-dependent promoters from the spinosyn biosynthetic gene cluster (BGC) were characterized and employed for dynamic repression of pyc and gltA2, resulting in increased spinosyn titers by 44-68% while maintaining robust growth. Finally, combined static and dynamic repression of these six targets simultaneously achieved over a 2-fold increase of spinosyn production. Collectively, integrated static and dynamic CRISPRi-based reprogramming of primary metabolic pathways in S. spinosa achieved a balance between growth and secondary metabolism, thereby leading to spinosyn overproduction. This strategy has broad potential applicability in other actinomycetes for natural product overproduction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences, Shanghai Normal University, Shanghai 200234, China.
- State Key Laboratory of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, China.
- Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai 200240, China.
ORCID-Profile: Wenfang Wang, Shaoxin Chen, Minjuan Xu, Yinhua Lu
Förderung
- National Key Research and Development Program of China
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Wang, W., Liu, H., Yang, Z., Wang, L., Li, W., He, H., Chen, S., Xu, M., & Lu, Y. (2025). Enhancement of Spinosyn Production by Integrating a Static and Dynamic CRISPRi-Mediated Metabolic Switch in Saccharopolyspora spinosa. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.5c08276
Vancouver
Wang W, Liu H, Yang Z, Wang L, Li W, He H, et al. Enhancement of Spinosyn Production by Integrating a Static and Dynamic CRISPRi-Mediated Metabolic Switch in Saccharopolyspora spinosa. Journal of Agricultural and Food Chemistry. 2025. doi:10.1021/acs.jafc.5c08276
BibTeX
@article{Wang2025,
author = {Wang, Wenfang and Liu, Hewei and Yang, Zhen and Wang, Liyang and Li, Wenqin and He, Huiyan and Chen, Shaoxin and Xu, Minjuan and Lu, Yinhua},
title = {Enhancement of Spinosyn Production by Integrating a Static and Dynamic CRISPRi-Mediated Metabolic Switch in Saccharopolyspora spinosa},
journal = {Journal of Agricultural and Food Chemistry},
year = {2025},
doi = {10.1021/acs.jafc.5c08276}
}
EUVIMED